This study aimed to clarify the factors related to subclinical arteriosclerosis, including the histopathological severity of the disease and PNPLA3 gene polymorphisms, in NAFLD patients. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.